Natural Chalcones for the Management of Obesity Disease

Int J Mol Sci. 2023 Nov 3;24(21):15929. doi: 10.3390/ijms242115929.

Abstract

In the last decade, the incidence of obesity has increased dramatically worldwide, reaching a dangerous pandemic spread. This condition has serious public health implications as it significantly increases the risk of chronic diseases such as type 2 diabetes, fatty liver, hypertension, heart attack, and stroke. The treatment of obesity is therefore the greatest health challenge of our time. Conventional therapeutic treatment of obesity is based on the use of various synthetic molecules belonging to the class of appetite suppressants, lipase inhibitors, hormones, metabolic regulators, and inhibitors of intestinal peptide receptors. The long-term use of these molecules is generally limited by various side effects and tolerance. For this reason, the search for natural alternatives to treat obesity is a current research goal. This review therefore examined the anti-obesity potential of natural chalcones based on available evidence from in vitro and animal studies. In particular, the results of the main in vitro studies describing the principal molecular therapeutic targets and the mechanism of action of the different chalcones investigated were described. In addition, the results of the most relevant animal studies were reported. Undoubtedly, future clinical studies are urgently needed to confirm and validate the potential of natural chalcones in the clinical prophylaxis of obesity.

Keywords: adipocyte differentiation; anti-obesity; browning process; lipid accumulation; natural chalcones.

Publication types

  • Review

MeSH terms

  • Animals
  • Appetite Depressants*
  • Chalcones* / chemistry
  • Chalcones* / pharmacology
  • Chalcones* / therapeutic use
  • Diabetes Mellitus, Type 2* / drug therapy
  • Obesity / drug therapy
  • Obesity / metabolism

Substances

  • Chalcones
  • Appetite Depressants

Grants and funding

This research received no external funding.